← Leaderboards
Michael Clarke
University Of Michigan At Ann Arbor
$18,879,458
Attributed
$20,288,933
Total exposure
19
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.1M · FY2005–18$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$37,842,839 · 22
By mechanism
P01$16,110,167 · 7
U54$7,916,360 · 3
R01$5,557,746 · 5
U01$5,303,945 · 2
RF1$2,065,131 · 1
S10$663,871 · 1
Top collaborators
- Sylvia Katina Plevritis5 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Lan Coffman$1,681,245
- Shuichi Takayama$11,517,196
- Gary D Luker$13,466,981
- Vernon K. Sondak$499,486
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGene ExpressionStem CellsTumorMalignant NeoplasmsLeadCancer CellSelf-RenewalSolid NeoplasmFlow CytometryMolecularCancer Stem CellUniversitiesLaboratoriesGrantTissuesGenesTherapeutic TargetInsightTechnologyPathway InteractionsMalignant Breast NeoplasmMaintenanceCell Physiology
Grant awards (76)
Targeting Senescence pathways in Alzheimer's disease$2,065,131
RF1 · FY2018 · AG · contact PI
Clinically-Relevant Regulatory Networks in the Lung Tumor Microenvironment$557,978
U01 · FY2015 · CA
Self-renewal of Normal and Leukemic Stem Cells$292,109
R01 · FY2015 · CA · contact PI
Clinically-Relevant Regulatory Networks in the Lung Tumor Microenvironment$533,147
U01 · FY2014 · CA
Cellular hierachy of ER- breast cancers in different ethnic groups$455,316
U01 · FY2014 · CA · contact PI
Self-renewal of Normal and Leukemic Stem Cells$282,911
R01 · FY2014 · CA · contact PI
Identification of cancer stem cell therapeutic targets$1,626,731
P01 · FY2013 · CA · contact PI
Clinically-Relevant Regulatory Networks in the Lung Tumor Microenvironment$537,303
U01 · FY2013 · CA
Cellular hierachy of ER- breast cancers in different ethnic groups$449,650
U01 · FY2013 · CA · contact PI
Identification of Self-renewal pathways in Cancer Stem Cells and Development of T$349,918
P01 · FY2013 · CA · contact PI
Animal Core$277,116
P01 · FY2013 · CA · contact PI
Self-renewal of Normal and Leukemic Stem Cells$273,740
R01 · FY2013 · CA · contact PI
Adminstrative Core$49,448
P01 · FY2013 · CA · contact PI
Identification of cancer stem cell therapeutic targets$1,733,162
P01 · FY2012 · CA · contact PI
Clinically-Relevant Regulatory Networks in the Lung Tumor Microenvironment$588,516
U01 · FY2012 · CA
Cellular hierachy of ER- breast cancers in different ethnic groups$505,636
U01 · FY2012 · CA · contact PI
Identification of Self-renewal pathways in Cancer Stem Cells and Development of T$373,536
P01 · FY2012 · CA · contact PI
Animal Core$294,820
P01 · FY2012 · CA · contact PI
Self-renewal of Normal and Leukemic Stem Cells$290,764
R01 · FY2012 · CA · contact PI
Adminstrative Core$52,609
P01 · FY2012 · CA · contact PI
Identification of cancer stem cell therapeutic targets$1,735,845
P01 · FY2011 · CA · contact PI
Clinically-Relevant Regulatory Networks in the Lung Tumor Microenvironment$602,006
U01 · FY2011 · CA
Cellular hierachy of ER- breast cancers in different ethnic groups$520,754
U01 · FY2011 · CA · contact PI
Identification of Self-renewal pathways in Cancer Stem Cells and Development of T$374,864
P01 · FY2011 · CA · contact PI
Animal Core$294,831
P01 · FY2011 · CA · contact PI
Self-renewal of Normal and Leukemic Stem Cells$290,366
R01 · FY2011 · CA · contact PI
Adminstrative Core$52,611
P01 · FY2011 · CA · contact PI
Identification of cancer stem cell therapeutic targets$1,792,219
P01 · FY2010 · CA · contact PI
Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and St$927,604
U54 · FY2010 · CA · contact PI
BD FACSAria II$663,871
S10 · FY2010 · RR · contact PI
Cellular hierachy of ER- breast cancers in different ethnic groups$553,639
U01 · FY2010 · CA · contact PI
Colon Cancer Stem Cells and their Stroma$391,980
U54 · FY2010 · CA · contact PI
Identification of Self-renewal pathways in Cancer Stem Cells and Development of T$384,365
P01 · FY2010 · CA · contact PI
Animal Core$301,214
P01 · FY2010 · CA · contact PI
Adminstrative Core$53,752
P01 · FY2010 · CA · contact PI
Identification of cancer stem cell therapeutic targets$1,836,874
P01 · FY2009 · CA · contact PI
Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and St$1,279,700
U54 · FY2009 · CA · contact PI
Colon Cancer Stem Cells and their Stroma$543,818
U54 · FY2009 · CA · contact PI
Identification of Self-renewal pathways in Cancer Stem Cells and Development of T$372,073
P01 · FY2009 · CA · contact PI
Animal Core$291,518
P01 · FY2009 · CA · contact PI
Adminstrative Core$52,020
P01 · FY2009 · CA · contact PI
PROG 3- CANCER STEM CELLS$20,909
P30 · FY2009 · CA · contact PI
Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and St$1,018,391
U54 · FY2008 · CA · contact PI
Colon Cancer Stem Cells and their Stroma$435,916
U54 · FY2008 · CA · contact PI
Self-Renewal of Normal and Leukemic Stem Cells$283,054
R01 · FY2008 · CA · contact PI
PROG 3- CANCER STEM CELLS$20,369
P30 · FY2008 · CA · contact PI
Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and St$1,238,550
U54 · FY2007 · CA · contact PI
Colon Cancer Stem Cells and their Stroma$529,824
U54 · FY2007 · CA · contact PI
Self-Renewal of Normal and Leukemic Stem Cells$282,663
R01 · FY2007 · CA · contact PI
PROG 3- CANCER STEM CELLS$16,966
P30 · FY2007 · CA · contact PI
2007 Gordon Research Conference- Cancer and Stem Cells$16,000
R13 · FY2007 · CA · contact PI
Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and St$1,180,000
U54 · FY2006 · CA · contact PI
The Role of RGS18 in Mouse Hematopoiesis$345,290
R01 · FY2006 · HL · contact PI
Colon Cancer Stem Cells and their Stroma$327,976
U54 · FY2006 · CA · contact PI
ANALYSIS OF LEUKEMIA CELLS$311,576
R01 · FY2006 · CA · contact PI
Self-Renewal of Normal and Leukemic Stem Cells$290,719
R01 · FY2006 · CA · contact PI
Adminstrative Core$42,601
U54 · FY2006 · CA · contact PI
The Role of RGS18 in Mouse Hematopoiesis$344,250
R01 · FY2005 · HL
ANALYSIS OF LEUKEMIA CELLS$310,781
R01 · FY2005 · CA
Self-Renewal of Normal and Leukemic Stem Cells$282,285
R01 · FY2005 · CA
The Role of RGS18 in Mouse Hematopoiesis$344,250
R01 · FY2004 · HL
ANALYSIS OF LEUKEMIA CELLS$310,781
R01 · FY2004 · CA
Self-Renewal of Normal and Leukemic Stem Cells$282,285
R01 · FY2004 · CA
TARGETING PCD FOR CANCER THERAPY$361,000
P01 · FY2003 · CA
RGS18 in Mouse Hematopoiesis$343,126
R01 · FY2003 · HL
TARGETING PCD FOR CANCER THERAPY$1,084,031
P01 · FY2002 · CA
TARGETING PCD FOR LEUKEMIA TREATMENT$115,227
P01 · FY2002 · CA
TARGETING PCD FOR CANCER THERAPY$1,061,323
P01 · FY2001 · CA
TARGETING PCD FOR LEUKEMIA TREATMENT$115,227
P01 · FY2001 · CA
MOLECULAR ANALYSIS OF HEMATOPOIESIS$0
P01 · FY2001 · DK
TARGETING PCD FOR CANCER THERAPY$678,476
P01 · FY2000 · CA
P53 TRAFFICKING DURING CELL CYCLE$230,005
R01 · FY2000 · CA
TARGETING PCD FOR LEUKEMIA TREATMENT$198,353
P01 · FY2000 · CA
MOLECULAR ANALYSIS OF HEMATOPOIESIS$197,004
P01 · FY2000 · DK
RUTHENIUM CONTAINING METALLOPHARMACEUTICALS$166,791
R01 · FY2000 · GM
TECHNOLOGIES GENERATION OF FULL-LENGTH MAMMALIAN CDNA$151,375
R21 · FY2000 · CA